Frequency Therapeutics said today that it closed a $32 million Series A round, led by CoBro Ventures. Morningside Ventures, Emigrant Capital Corp., Korean Investment Partnership, Alexandria Real Estate Equities and other groups also invested in the round.
The company has developed a proprietary combination of small molecule drugs that they plan to inject in the ear, stimulating the regrowth of sensory hair cells to treat chronic noise-induced hearing loss.
Get the full story at our sister site, Drug Delivery Business News.
The post Frequency raises $32m in Series A for hearing loss therapy appeared first on MassDevice.
from MassDevice http://ift.tt/2p4sCdc
Cap comentari:
Publica un comentari a l'entrada